Work

A multi-institution phase I trial of ruxolitinib in chronic myelomonocytic leukemia (CMML).

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.7021

Authors: Eric Padron, Amy Elizabeth Dezern, Kris Vaddi, Peggy A Scherle, Qing Zhang, Yan Ma, Maria Balasis, Sara Tinsley, Hanadi Ramadan, Casandra Zimmerman, David P. Steensma, Gail J. Roboz, Jeffrey E. Lancet, Alan F. List, Mikkael A. Sekeres, Rami S. Komrokji

Institutions: Moffitt Cancer Center, Sidney Kimmel Comprehensive Cancer Center, Incyte (United States), Cleveland Clinic, Dana-Farber Cancer Institute, NewYork–Presbyterian Hospital, Cornell University

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2499795338

Cites:

Cited by: 3

Related to: 10